Beijing (1)

Nasopharyngeal Carcinoma (1)

Recurrent or Metastatic (1)

Not yet recruiting (1)

phase 3 (1)

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. (1)

cisplatin (1)

gemcitabine (1)

kl-a167 (1)

placebo (1)

drug (1)

Industry (1)

Interventional (1)

recurrent or metastatic

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Mar 23, 2022